Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001638599-15-000381)

Filing Details

Accession Number:: 0001638599-15-000381
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-03 16:20:35
Reporting Period:: 2015-12-01

Filing Date:: 2015-12-03
Accepted Time:: 2015-12-03 16:20:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
810509	Navidea Biopharmaceuticals Inc.	NAVB	In Vitro & In Vivo Diagnostic Substances (2835)	311080091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1195766	L Brent Larson	5600 Blazer Parkway, Suite 200 Dublin OH 43017-7550	Evp, Cfo, Treas & Sec'y	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-12-01	12,500	$1.50	222,237	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sales effected pursuant to a 10b5-1 trading plan adopted by Mr. Larson on March 13, 2015.
Weighted average of sales prices ranging from $1.49 to $1.51 per share. Mr. Larson undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.